CFG
AMGN icon

Cambridge Financial Group’s Amgen AMGN Stock Holding History

Cambridge Financial Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-59,758
Closed -$6.47M – 32
2013
Q2 		$6.47M Buy
+59,758
New +$6.2M 3.26% 21

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cambridge Financial Group's AMGN Position: Q3 2013 in Review

Cambridge Financial Group sold out of Amgen (AMGN) in Q3 2013, closing a stake of 59,758 shares — an estimated $6.47M sold.

Cambridge Financial Group first reported a position in AMGN in Q2 2013 and held it in 1 quarter. The position peaked at $6.47M in Q2 2013. 1,062 funds tracked by Wall St. Rank hold AMGN as of Q3 2013.

  • Cambridge Financial Group reported no remaining Amgen position as of Q3 2013 after selling out during the quarter.
  • Cambridge Financial Group sold 59,758 Amgen shares in Q3 2013, an estimated $6.47M.
  • Cambridge Financial Group first reported a position in Amgen in Q2 2013 and held it in 1 quarter.
  • Cambridge Financial Group's Amgen position peaked at $6.47M in Q2 2013.
  • 1,062 funds tracked by Wall St. Rank held Amgen as of Q3 2013.

Based on Cambridge Financial Group's 13F filing for Q3 2013, filed 18 Nov 2013.